Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMAP + GM-CSF in Advanced Uterine Leiomyosarcoma
NCT00033644Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Mar 2002
- Primary completion
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes, DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of dacarbazine, mitomycin c, doxorubicin, cisplatin, sargramostim in uterine leiomyosarcoma (uLMS), sponsored by GOG Foundation. Started Mar 2002; status: terminated.
02
Drugs
dacarbazinemitomycin cdoxorubicincisplatinsargramostim
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT00033644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033644.